Measles Rubella Vaccination Campaign Kerala
Abstract
South-East Asia Regional Countries have resolved (WHO SEAR resolution) to eliminate Measles and control Rubella/Congenital Rubella syndrome (CRS) by year 2020. India being a signatory is fully committed to it and in that direction, as per the recommendation of the National Technical Advisory Group on Immunization (NTAGI) in June, 2014 which has recommended the introduction of measles-rubella vaccine in routine immunization program, following a nation-wide MR campaign, and replacing both doses of measles vaccine at 9-12 months and 16-24 months with MR vaccine under routine immunization immediately.
When publishing with Kerala Medicial Journal (KMJ), authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Work includes the material submitted for publication and any other related material submitted to KMJ. In the event that KMJ does not publish said work, the author(s) will be so notified and all rights assigned hereunder will revert to the author(s).
The assignment of rights to KMJ includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, include in indexes or search databases in print, electronic, or other media, whether or not in use at the time of execution of this agreement.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
The author(s) hereby represents and warrants that they are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work based on substantially similar data has been submitted to another publication.
